4 results

• FDA Pauses Clozapine REMS Program Enforcement Due to High Volume of Patient Delays

  December 16, 2021

  Martha Garcia

  The FDA has suspended a Clozapine REMS program's enforcement measures after numerous reports of patients suffering delays in getting the antipsychotic drug.

• Clozaril, Similar Drugs Linked To Life-Threatening Bowel Problems, FDA Warns

  January 30, 2020

  Irvin Jackson

  The FDA warns that clozapine can cause potentially severe bowel problems which could result in injury, hospitalization or death.

• Psychotropic Drugs May Cause Weight Gain By Altering Your Genes: Study

  January 17, 2020

  Martha Garcia

  A new study indicates psychotropic drugs cause genetic changes which leads to weight gain.

• Clozapine Neutropenia Risk Results in FDA Warning Update

  September 16, 2015

  Russell Maas

  Amid concerns about the potential side effects of clozapine, federal health officials are requiring new warnings and patient monitoring for...